Loading...
DMS Imaging SA
ASIT.BR•EURONEXT
Healthcare
Biotechnology
€0.23
€0.00(0.00%)
DMS Imaging SA (ASIT.BR) Company Profile & Overview
Explore DMS Imaging SA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
DMS Imaging SA (ASIT.BR) Company Profile & Overview
DMS Imaging SA, a biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium and internationally. Its lead product is gp-ASIT+, which is in the Phase III trial for the treatment of grass pollen rhinitis. The company is also developing hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy. ASIT Biotech S.A. was incorporated in 1997 and is based in Liege, Belgium.
SectorHealthcare
IndustryBiotechnology
CEOThierry Legon
Contact Information
Company Facts
20 Employees
IPO DateMay 11, 2016
CountryBE